In the BioHarmony Drug Report Database
Lenzilumab
Lenzilumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor.
Trade Name
|
|
|---|---|
Common Name
|
lenzilumab |
ChEMBL ID
|
CHEMBL3707325 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: fully human, immunomodulating |
Image (chem structure or protein)
